← Back to Clinical Trials
Recruiting NCT06624826

NCT06624826 Visual Performance of an Extended Depth of Focus IOL in an Emmetropic or Monovision Modality

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06624826
Status Recruiting
Phase
Sponsor Prim. Prof. Dr. Oliver Findl, MBA
Condition Cataract
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-10-01
Primary Completion 2025-10-01

Trial Parameters

Condition Cataract
Sponsor Prim. Prof. Dr. Oliver Findl, MBA
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 21 Years
Max Age 105 Years
Start Date 2024-10-01
Completion 2025-10-01
Interventions
Emmetropic modalityMonovision modality

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Comparison of the visual performance of a refractive extended depth of focus intraocular lens in an emmetropic or monovision modality

Eligibility Criteria

Inclusion Criteria: * Age-related bilateral cataract * Age 21 or older * Visual acuity \> 0.05 * Axial length: 21.00-27.00mm * Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically relevant * Written informed consent prior to surgery Exclusion Criteria: * Active ocular disease (e.g chronic uveitis, diabetic retinopathy, chronic glaucoma not responsive to medication, corneal dystrophies, etc.) precluding good post-operative visual acuity * Relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX) * Irregular astigmatism on corneal tomography * Pronounced dry eye disease * Previous ocular surgery or trauma * Persons who are pregnant or nursing (pregnancy test will be taken in women of reproductive age)

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology